Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites
Authors:
- Manfred KaufmannMKManfred Kaufmann
- Hans SchmidHSHans Schmid
- Jutta HofmannJHJutta Hofmann
- Bertram WiedenmannBWBertram Wiedenmann
- Andreas KistAKAndreas Kist
- Joachim KempeniJKJoachim Kempeni
- Erich SchlickESErich Schlick
- Gunther BastertGBGunther Bastert
- Burkhard KommerellBKBurkhard Kommerell
- Daniela MännelDMDaniela Männel
- 1 January 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (2) , 121-125
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]Blood, 1990
- Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factorBritish Journal of Cancer, 1989
- Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomasJournal of Cancer Research and Clinical Oncology, 1989
- Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factorBlood, 1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Intraperitoneal Administration of Interleukin-2 in Patients With CancerArchives of Surgery, 1986
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984
- A reproducible microanalytical method for the detection of specific RNA sequences by dot-blot hybridizationAnalytical Biochemistry, 1984
- A new concept of ascitic fluid distributionAmerican Journal of Roentgenology, 1976
- Evaluation of Ascites by UltrasoundRadiology, 1970